Polyglutamine disease-associated allele carriers in the general population


  • In the general population there is a high prevalence of carriers of intermediate and pathological ranges of polyglutamine disease-associated alleles (PDAGs).

Why this matters

  • The number of people who may develop a polyglutamine disease or bear children with a de novo mutation is substantially larger than previously estimated.